New Glooko Clinic Dashboard

New Glooko Clinic Dashboard with Glooko Mobile App and Glooko TransmitterWhen healthcare professionals manage a large population of patients with diabetes, they often lack a clear, organized, and comprehensive view of patients’ pertinent health data.

To help address this challenge, we designed the new clinic dashboard in the Glooko diabetes management platform. Available in select countries, the dashboard helps healthcare providers, including primary care providers, endocrinologists, and nurses, at hospitals, health systems, and clinics streamline their diabetes population health management.

Developed for busy healthcare professionals, the new Glooko clinic dashboard is based on TIDE (Timely Interventions for Diabetes Excellence) metrics to help address the challenge of managing a large diabetes patient population. This user-friendly view provides at-a-glance insights into patient population trends and key clinic metrics, making it easier for the entire care team to interpret complex data and guide more efficient decision-making and clinic strategy.

Built on TIDE Metrics for Smarter Diabetes Care

Leveraging evidence-based risk identification logic developed by Stanford researchers to further enhance clinical insights, personalize care, and demonstrate scalable, cost-effective outcomes, the TIDE dashboard, which demonstrated in a 2022 study to reduce screen time for healthcare providers reviewing patient data by 86%, is a powerful tool designed to help clinical teams manage large populations of patients with type 1 diabetes.

The TIDE dashboard uses smart algorithms to analyze and remotely monitor data from continuous glucose monitoring (CGM) devices, helping care teams efficiently and effectively manage their patients’ health. Using essential glucose measures like Time in Range and hypoglycemia, the TIDE model also prioritizes which patients need immediate attention by sorting them by clinical risk, so healthcare providers can focus on those who need it most without sifting through every patient’s data individually.

The TIDE model-based Glooko clinic dashboard offers our professional users a user-friendly way to tackle the challenge of managing a large patient population with three intuitive sections.

Understand Patient Population At-A-Glance

The Population Metrics section of the new Glooko clinic dashboard helps care teams understand the overall health and engagement of their clinic’s patient population in a centralized and concise view. This space displays the total number of patients with diabetes, identifies who is actively monitoring their blood glucose by blood glucose monitors (BGM) or CGM, and shows which patients have completed their Glooko account registration and are actively syncing their health data remotely with our connected care platform.

By centralizing these metrics, this comprehensive section of the dashboard helps healthcare providers shape clinic strategy more efficiently and better understand which patients to contact to activate their Glooko account to make more informed decisions based on synced health data.

New Glooko Clinic Dashboard's Population Metrics

Prioritize Care Based on Key CGM Metrics

The CGM Patient Risk Stratification section of the new Glooko clinic dashboard helps healthcare providers prioritize patient care and gives care teams a streamlined view of their patient population, sorted by clinical risk based on key glucose metrics from CGMs. Care teams can easily spot which patients need attention first. The dashboard ranks patients using indicators like Time in Range, Time Below Range, and other key CGM indicators, so healthcare providers can prioritize outreach and interventions based on the most important CGM data, making it easier for them to focus their time on the patients who need it most.

New Glooko Clinic Dashboard's CGM Risk Stratification

Boost Patient Engagement and Optimize Care

The Engagement Metrics module of the new Glooko clinic dashboard helps healthcare providers spot engagement gaps in their patient population over the past 90 days.

The Patient Account Status section examines the patient population to see if they’ve set-up their Glooko account based on Activated, Invited Pending, Never Invited, and Likely Duplicates. With these key metrics, care teams can quickly see which patients with diabetes haven’t completed the sync to Glooko with their diabetes and health monitoring devices as well as the activation process, allowing for more efficient follow-up and activation.

In the Sync Methods section, care teams can see how patients with diabetes are syncing their data with Glooko. When more health data is synced with Glooko from the cloud, Glooko Mobile App, Transmitter, or Uploader, care teams can make more informed and timely treatment decisions.

New Glooko Clinic Dashboard's Engagement Metrics

Experience Glooko’s New Clinic Dashboard

Ready to see how the intuitive, new Glooko clinic dashboard can optimize diabetes population health management at your clinic, hospital, or health system? Contact our team for a demo.

Glooko CEO Mike Alvarez on the acquisition of Monarch Medical Technologies

Glooko CEO Mike AlvarezToday marks an important milestone in our mission to transform diabetes care. I am excited to share that Glooko has acquired Monarch Medical Technologies, creators of the EndoTool® Glucose Management System.

With this acquisition, Glooko is positioned to become the only diabetes management company with the potential to connect the full continuum of care — from home to hospital and back again. By bringing together EndoTool’s proven inpatient insulin dosing technology with Glooko’s leading outpatient platform, we aim to create a future where care is seamless, safer, and more supportive for both people living with diabetes and healthcare providers.

For patients, this means fewer disruptions as they move between settings, reduced risk of dangerous glycemic events, and more confidence that their care is connected. For healthcare providers, it means access to tools that simplify complex insulin management, standardize protocols, and free up time to focus on what matters most, which is caring for people.

This step also sets the foundation for Glooko’s future: using data and AI to help clinicians anticipate risks earlier, personalize care at scale, and improve outcomes under value-based models. By aligning advanced technology with clinical guidelines and EHR workflows, we can help hospitals and health systems deliver higher-quality care while lowering costs.

Our mission has always been clear: to simplify diabetes management, strengthen connections across the care team, and improve lives. This acquisition represents an important stride toward that vision.

Together, we are building a future where diabetes care is more connected, proactive, and patient-centered than ever.

Glooko Diabetes Management Web 25.2 and Mobile 6.12 Release Banner

We’re excited to announce the latest updates to Glooko Web 25.2 and Mobile 6.12, which are designed to help healthcare providers and people with diabetes by streamlining workflows, providing a new population management dashboard to triage at-risk patients and review population-level metrics, improving data visualizations, and giving care teams more powerful data from compatible devices to enhance diabetes management.

Glooko New Clinic Dashboard for Diabetes ManagementIntroducing the New Clinic Dashboard

In this release, we launched a new clinic dashboard in the U.S. designed to give healthcare professionals at-a-glance insights into population health trends and clinic management metrics. This enhancement makes it easier to interpret complex data and guide decisions and clinic strategy more efficiently across care teams.

Other new clinic dashboard highlights include:

Banner Notification for Missing MRN

Glooko’s connected care platform prioritizes deep EHR integration to bring actionable diabetes data into the systems clinicians already use. To help maintain EHR data integrity and ensure patient matching is seamless, Glooko introduced a clear dismissible banner on the patient dashboard to notify clinicians when a Medical Record Number (MRN) is required but missing.

Glooko EHR Integrity with Medical Record Number Notification

Tandem Basal Profile Switches

A new icon in DayView and WeekView on the Glooko diabetes management platform identifies when a patient changes their Tandem Personal Profile to give better context for insulin delivery.

GLP-1 Dose Enhancements

GLP-1 doses will now be displayed in the Glooko Web and Mobile software with improved messaging and clinical disclaimers. Healthcare professionals will now receive relevant dose range notifications while also providing precise dose information to support better oversight and patient adherence, while patients will see exact GLP-1 doses up to two decimal places as injected.

Device Type Display in PDFs

Glooko will now display controller device types in the PDF Settings Report, helping clinicians more clearly understand where data originated for users of Omnipod® 5 and other select devices. The report will specifically say on a clear device label the upload method (e.g., Android, iOS, Locked Down Controller) used by the patient.

Glooko Diabetes Management App Insulin StatsUpdated Insulin Statistics Design

The Glooko Mobile App’s insulin card has been redesigned to enhance clarity and consistency, particularly benefiting users with insulin pump data. This update aims to improve the understanding of insulin averages and minimize confusion between pump and total insulin values by displaying data in one unified insulin card.

More Information on the Latest Glooko Release

For more detailed information about these new features intended to enhance clinical practices and transform diabetes, be sure to check the full release notes on our Glooko Support page.

Glooko and Abbott FreeStyle Libre CGMs in the United States

At Glooko, we are committed to simplifying diabetes insights and management for people living with diabetes and healthcare providers alike. That’s why our platform is compatible with more than 200 diabetes and health monitoring devices and growing.

As a company, we could not be more pleased to share that we recently expanded our capabilities to integrate with Abbott’s FreeStyle Libre CGMs in the United States. This integration brings glucose data to more clinics and health systems in our all-in-one solution for diabetes management.

This milestone is more than just a technological advancement — it’s about empowering people with Type 1, Type 2, and gestational diabetes, as well as prediabetes, to become active owners in their health. By combining the precision of Abbott’s FreeStyle Libre CGMs with Glooko’s comprehensive platform, we can provide people living with diabetes and their care teams, including endocrinologists and nurses, with a unified, holistic view of diabetes management and irrefutable information.

From glucose trends to lifestyle behaviors like diet and physical activity, this latest integration ensures that critical insights are easily accessible when and where they are needed most. For healthcare providers and health systems, this means the ability to seamlessly access and analyze patients’ CGM data through Glooko and established electronic health record (EHR) solutions, more informed decision-making, and improved patient outcomes. For people living with diabetes, it means greater confidence in their care and health.

As the number of people with diabetes continues to grow, the need for seamless, data-driven solutions has never been greater. Our new integration with Abbott’s FreeStyle Libre CGMs represents a significant step forward in delivering better, more connected care. This partnership is sure to have a positive impact on the millions of people who rely on FreeStyle Libre CGMs and Glooko.

Glooko and Abbott FreeStyle Libre CGMs in the United States

Glooko Web 25.1 and Mobile 6.11

As part of our ongoing commitment to supporting healthcare providers and people living with diabetes, we’re excited to share the latest enhancements and features now available in Glooko Web 25.1 and Mobile 6.11. These updates are designed to streamline workflows, improve patient engagement and security, and provide care teams with more robust tools to manage diabetes care effectively.

Patient Notes and Medications in Week View

Care teams and people living with diabetes can now view notes and medication entries added to the Glooko Mobile and Web App directly in Week View, both online and in PDF reports. These entries appear in a new collapsible “Events” section below each day, making it easier to contextualize trends in glucose data and treatment behaviors.

Glooko Web 25.1 and Mobile 6.11

Streamlined Week View PDF Reports

In our new release, Week View PDFs are now cleaner and more efficient. Sections without data will be automatically hidden, allowing more patient data over a few days to fit on each page.

The glucose and statistics sections will always remain, and a single, comprehensive legend will now appear at the end of the report.

Smarter Defaults in the PDF Wizard for Hybrid Closed Loop Systems

Designed to streamline reporting workflows and help care teams quickly access the most meaningful insights, the Glooko PDF Wizard now automatically pre-selects the most relevant reports, including Summary, Week, Daily, and Devices, when a patient uses a Hybrid Closed Loop System like Omnipod® 5, Tandem t:slim X2 with Control-IQ technology, or mylife Loop powered by CamAPS® FX.

Care teams can still customize the selections as needed.

Enhanced Security in the Glooko Mobile App

Glooko Mobile App SecurityAt Glooko, we’re committed to the security and safety of our platform users.

People living with diabetes, including those under age 18, can now manage their login credentials (email and password) through a new Login Security section in the Glooko Mobile App’s Account Settings. We’ve also expanded support for two-factor authentication (2FA) to users to ensure an extra layer of protection.

Explore More Updates

For more detailed information about the new features designed to simplify diabetes management, be sure to check out the full release notes on the Glooko Support Center.

Glooko EHR Integrations

 

At Glooko, we empower healthcare providers with the tools and insights they need to make informed decisions quickly and easily to improve the health outcomes of their patients living with diabetes.

With nearly half of physicians reporting at least one burnout symptom in a recent study from the American Medical Association, it’s critical we make diabetes data management simpler to not overburden those providing care.

That’s why the Glooko platform integrates with leading electronic health record (EHR) systems in the U.S., including Epic, Oracle Health, MEDITECH, Greenway Health, eClinicalWorks, NextGen, and Athenahealth, making our diabetes management platform seamlessly and securely available within this critical healthcare technology and eliminating the need to platform switch.

Why EHR Integrations Matter

Glooko EHR IntegrationDiabetes care is complex, and healthcare providers face the challenge of managing patient data across multiple systems. In an era where time is precious and clinicians are already spending much of their time on administrative tasks, clinicians need timely access to the most relevant health data without the inefficiencies of navigating multiple data platforms.

By integrating Glooko into EHRs, we streamline how healthcare providers access diabetes data, enabling them to provide the highest quality care. Our integrations provide clinicians and care teams with immediate access to comprehensive data from more than 200 diabetes and health monitoring devices used by their patients, eliminating the need for additional logins and manual data entry by people living with diabetes each day.

EHR integrations not only optimize existing systems, but they also have the potential to enhance clinical decision-making by giving clinicians the full picture of a person’s health. It empowers them to make faster, more informed treatment decisions. That’s why health systems spend $2.5 million to $1.2 billion on EHR integrations each year. They’re powerful and their care teams can reap the benefits of reduced documentation burden.

How It Works

By leveraging SMART on FHIR technology and HL7, standard interoperability frameworks, Glooko integrates with existing EHR systems at hospitals and health systems. Healthcare providers can then access patients’ timely glucose data, medication logs, activity levels, food intake, and much more without leaving the EHR.

The integrations support healthcare systems by offering a single, unified view of a person’s diabetes information, all while ensuring secure, HIPAA-compliant data exchange. The technology is designed to streamline workflows, making it easier for clinicians to focus on what truly matters: providing quality care for their patients.

Glooko EHR Integrations

A Step Toward the Future of Diabetes Care

Following the COVID-19 pandemic, clinical teams who provide care to the more than 38 million people in the U.S. living with diabetes have greatly declined in number, furthering the urgent need for seamless, data-driven solutions to help reduce administrative burdens and workloads that drive burnout.

And the burnout by clinicians and care teams is only going to grow greater as 98 million American adults have prediabetes, according to the CDC.

By optimizing and integrating with leading EHR systems, Glooko is taking a significant step forward in transforming diabetes management and reducing extra steps taken by healthcare providers to improve the quality of care. Our integrations help improve workflows, limit platform switching, simplify clinical decision-making, and support better outcomes for both healthcare providers and people with diabetes.

These integrations represent our ongoing commitment to delivering cutting-edge, interoperable solutions that empower both clinical teams and patients in making diabetes easier to manage.

Ready to Learn More?

Healthcare providers and hospital systems can access EHR integrations by reaching out to our dedicated team for a demo. With robust support from our dedicated team, some integrations, like with Epic, can be up and running within a weeks, making it easier than ever to take advantage of the benefits Glooko has to offer.

To learn more about Glooko’s many EHR integrations, visit our Integration Portal.

Glooko Food Tracker

Glooko's Trisha MartinezFood and nutrition play a vital role in achieving a healthy lifestyle. This is particularly important in diabetes management, especially for people living with Type 2 diabetes.

In the Glooko Mobile App available on the App Store and Google Play Store, people living with diabetes can easily log what they eat at home or while on the go using our food tracking feature, a popular functionality that always receives praise from our users.

Through our integration with the world’s largest dietitian-verified grocery database of more than 1 million items from over 46,000 grocery brands, users of the Glooko Mobile App can accurately track their meals and snacks in a variety of ways and create a personal log to better understand how food and nutrition impacts their diabetes.

Glooko offers many options for logging food intake:

By viewing food and nutrition data, including carbohydrates, calories, fats, and proteins, alongside insights from their connected diabetes and health monitoring devices, medications, and insulin, users can uncover trends and make smarter food choices. Since people don’t need to log into multiple platforms to manage both their diabetes and nutrition data, we’ve recently seen an increase in food logging frequency and more tracking of localized food items around the world.

More ways to eat smart and track more effectively using the Glooko Mobile App

To better serve the diverse needs of users around the globe, Glooko has localized food items searchable in German, French, Spanish, Italian, UK English, and US English to support people living with diabetes in these regions.

Frequent users can also save time by creating custom food entries for their favorite meals — perfect for quick re-logging of their go-to foods.

To better serve the diverse needs of users around the globe, Glooko has localized food items searchable in German, French, Spanish, Italian, UK English, and US English to support people living with diabetes in these regions.

Glooko Mobile App users can complement their food logging with quick notes using free text or the dropdown menu option to provide details like miscalculated carbs, overeating, dining out, or skipped meals. These notes help communicate important context to their healthcare team who can provide more information dietary or medication recommendations as needed.

Share nutrition data with healthcare providers

While we’ve really focused on the benefits of food tracking for people living with diabetes, healthcare providers and care teams also benefit from this feature. They can view this logged nutrition data alongside their patients’ other health data in Glooko to have a more comprehensive view of everything affecting their patients’ diabetes.

The evolution of our food tracker

Glooko plans on further innovating its app to provide advanced food analysis tools, including micronutrients, more photos, and easier logging, and personalized nutrition insights with real-time feedback on how specific food choices directly impact a person’s health. An advanced, data-driven approach will empower people living with diabetes to make even timely, smarter, and more informed decisions about their health.

Download the Glooko Mobile App today

Ready to take diabetes management to the next level? Download the Glooko Mobile App from the App Store or Google Play Store and start logging food, tracking health data, and uncovering insights that support better living with diabetes.* *Not all product features are available in all countries.

*Not all product features are available in all countries.

Glooko Food Tracker

Glooko Mobile App RedesignGlooko Mobile App Home Screen for People with Diabetes

​​Today, we launched a sleek new look to the Glooko® Mobile App, which makes it easier for users with diabetes to navigate, organize their data in one place and share their data with their doctor and extended care team. We’ve also streamlined data visualization, so users can seamlessly view all their data at once.

The modern look and feel of the Home screen allows for quick access to the user’s most used actions, including seeing glucose trends, logging medication, and tracking food and exercise.

For new mobile app users getting started with Glooko, we’ve simplified the onboarding process and customized it to fit individual goals.

From easily connecting to their clinics and sharing reports with their care team to using the Quick Add slider to conveniently add food, insulin and exercise, the free Glooko Mobile App, available in the App Store and Google Play Store, goes where people with diabetes go.

Wondering what went into the redesign of our digital health app? We sat down with some of the Glooko team members, including Director of Product Design Amanda Martin, Product Designer Ben Stone and Product Manager Chase Sutton, who worked behind-the-scenes to learn more about the process.

Glooko Product Design Team

What were the goals and motivation behind the Glooko Home screen’s new look? How did you decide what features to highlight in the Home screen?

Glooko Mobile App Health Data for People with DiabetesWhile we always take into account feedback from our users, our team performed extensive research and interviews to see what opportunities existed for changes in the app that would result in the greatest improvements. Through this, we landed on focusing our efforts mostly on the Home screen, the onboarding process for new users, and modernizing the user experience.

In this high-impact space, we reimagined how to display insights for users through side-by-side and detailed charts and graphs with all the pertinent data, including its sources, in one place. We added Quick Add buttons for easily tracking food, insulin, medication and other actions important to people with diabetes.

Through our interviews, we learned that users like to feel connected to their doctors and care teams and view that as a major benefit of Glooko. We wanted our users to have a direct link to them, so we added to the Home screen an easy way to reach and share data with them.

We also learned that we needed to improve the onboarding experience by making it quicker to get started and sync diabetes devices. This process was a hurdle for users in the past and we sought to simplify it in the redesign. There’s now a space on the Home screen for new users who are looking to get started with Glooko.

What are some of the main takeaways from the redesign of the Glooko Mobile App? How will this help current and new users?

For both current and new users of Glooko, the updated navigation on the Home screen helps users access key features more efficiently as the older version had many features tucked away and hard to discover. We put popular features, like food logging and sharing data with care teams, front and center on the Home screen—all available with one scroll and featuring the latest synced data.

For new users, we really wanted to give them an easy onboarding experience. We learned that the earlier version of the Glooko app’s onboarding was somewhat complicated and could be viewed as a turn off for people just joining and looking to take full advantage of our digital health app.

The reimagined onboarding is guided and shows new users what to do in a very organized, “bite-sized” way that allows them to easily complete it at their own pace.

What’s the new onboarding process like? Is it easier and does it have less steps for new users?

We learned through our interviews that the onboarding process definitely needed an overhaul. Users would go to the first step of syncing their device and then never went any further with the process as they found it too difficult. Our takeaway was that we needed to get new users to the Home screen right away.

In the new process, users now start on the Home screen and can complete the onboarding tracker, which includes syncing their device, tracking their insulin and completing their Glooko profile, in any order and timeframe. Users now get to experience all the features of Glooko right out of the gate!

Glooko Onboarding Process for People with Diabetes

How did you take feedback from people living with diabetes when making these changes that improve the experience of the Glooko Mobile App?

Connecting with users and hearing from them is incredibly important to our design process.

We have a human-centered design team, so it was integral that we talked to actual Glooko users to hear their feedback. We took what we learned and brought sketches and concepts for improving the Glooko Mobile App back to them. It’s a cycle that we go through all the time, but one that we really valued in this project.

Our team had some great conversations during this process with users who synced once to those who were very active in the app and constantly logging food. Each user group who provided us with feedback helped inform our decisions in the redesign.

We also used insights from data in the app to verify our theories around user engagement during these interviews.

What’s some of the feedback you’ve received from test users on the new look?

Glooko Mobile App Weekly Overview for People with DiabetesThey’ve all been very excited about the improvements to the Glooko Mobile App.

We’ve received the most feedback about the modern look and feel, responsiveness and colors. Users are also pleased with the personalized way the data is displayed, whether it’s a continuous glucose meter, blood glucose meter or other compatible device.

The simplified, consistent and clean approach to the new experience will continue to resonate with our users—new and existing.

What other changes will be coming in the future to the Glooko Mobile App?

We have an ambitious and exciting roadmap for the mobile app, and much of it is focused on data.

We want users to better understand their overall health, so we’re looking to develop innovative and detailed charts and graphs to enable the next-generation of diabetes insights. These new data insights will give people with diabetes and their care teams the ability to make smarter decisions to improve their health.

Additionally, we’ll introduce personalized nudges that will help encourage behavior change and guide users to better lifestyle decisions in the coming future.

While all these future upgrades are very exciting, we’re giving both people with diabetes and their doctors the ability to see the power of Glooko and what connected care really is in our new reimagined version today.

The Glooko app is now available in the App Store and Google Play Store.

MKT-0434 01

Glooko Insulet Omnipod 5

Glooko is excited to share that our digital health platform for people with diabetes and related chronic conditions is compatible in the United States with Insulet Corporation’s Omnipod® 5 Automated Insulin Delivery (AID) System.

The automated insulin delivery system, which is composed of the Omnipod 5 App, the Pod and has Dexcom® G6 Continuous Glucose Monitor (CGM) System integration, received FDA clearance for use by individuals ages 2 and older with type 1 diabetes in 2022.

As the first tubeless AID system with smartphone control* in the U.S., Omnipod 5 integrates with the Dexcom G6 CGM System to automatically adjust insulin, help protect against highs and lows in glucose levels**, and simplify life for people with diabetes. The system’s innovative Pod uses SmartAdjust™ technology that continuously and automatically regulates insulin delivery based on a patient’s customized Target Glucose.

“With the many benefits provided by the Omnipod 5, we’re thrilled it’s compatible and available to Glooko users in the U.S.,” said David Conn, Glooko’s Executive Vice President of Partnerships and Alliances. “Our partnership with Insulet allowed us to be compatible from launch with this innovative new AID system designed for people looking to better manage their diabetes.”

Through our integration with Insulet, patients using the Omnipod 5 can connect their system to Glooko and upload their data from home via a cloud connection, expediting the time spent with healthcare providers. Healthcare providers can review the data uploaded and view standardized, comprehensive reports in the Glooko dashboard to help gain insights and make decisions to optimize care.

“The team at Insulet appreciates the support Glooko provided to make the launch of the Omnipod 5 possible and successful,” said Dr. Trang Ly, MBBS, FRACP, Ph.D., Senior Vice President and Medical Director, Insulet. “This System has been life-changing for so many people living with type I diabetes and we look forward to continuing to see its impact.”

Along with the Omnipod 5, the Glooko platform is also compatible with Insulet Corporation’s Omnipod DASH®.

At Glooko, we’re continuously increasing the number of devices that are compatible with our digital health platform, and over 3 million users around the globe have benefited in managing their health with our tools. We’re currently compatible with a majority of global diabetes and health monitoring devices on the market, which gives patients and their healthcare providers flexibility in managing their diabetes and related chronic conditions.

*For a list of compatible smartphone devices visit omnipod.com/compatibility

**Study in 240 people with T1D aged 6 – 70 years involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time with high blood glucose in adults/adolescents and children, standard therapy vs. 3-month Omnipod 5: 32.4% vs. 24.7%; 45.3% vs. 30.2%. Median time with low blood glucose in adults/adolescents and children, standard therapy vs. 3-mo Omnipod 5: 2.0% vs. 1.1%; 1.4% vs. 1.5%. Brown et al. Diabetes Care (2021).

Study in 80 people with T1D aged 2 – 5.9 years involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time in Target Glucose range (from CGM) for standard therapy vs Omnipod 5 = 57.2% vs. 68.1%. Average time in Target Glucose range (12AM -< 6AM) from CGM in standard therapy vs. Omnipod 5 = 58.2% vs 81.0%. Average A1c in standard therapy vs. Omnipod 5 = 7.4% vs. 6.9%. Median time with low blood glucose from CGM: standard therapy = 3.43% vs. 2.46%. Sherr JL, et al. Diabetes Care (2022).

MKT-0358 01

Glooko Mobile App Food Tracker for Diabetes

​​Tracking Food Intake in the Glooko Mobile App for DiabetesFood is a critical component in the management of diabetes.

​​People with diabetes can use the Glooko mobile app, available in the App Store and Google Play Store, to easily log their food intake and keep a historical account of how food affects their chronic condition.

The data from daily meals can be viewed alongside data from compatible diabetes and health monitoring devices, medications and insulin to reveal trends and patterns to better understand what is affecting a person’s diabetes

Tracking food consumption in our digital health app can be handled in multiple different ways, including by searching the food database, using voice capture or scanning a barcode.

The Food Tracker in the Glooko Mobile App for DiabetesThe Glooko mobile app simplifies tracking food consumption while allowing users to explore nutrition facts, including carbohydrates, calories, fats and proteins.

Frequent users of the food tracker can also create personalized custom food entries of their favorite meals, so they don’t need to re-add portions multiple times.

“The food tracker feature in our mobile app allows users to see how the food they’re consuming each day may affect their diabetes,” said Glooko Chief Product Officer Ed Marshall. “Being able to see all the data in one place gives users the ability to understand how they’re doing and make informed decisions about their health.”

Glooko Food Tracker for Diabetes

The Glooko mobile app and its food tracker feature is also constantly evolving to meet the needs of our global users.

To better support users in the U.K., France, Germany and Spain last year, we added unique regional food items that are searchable in British English, French, German and Spanish to our connected care app.

For handy ways on how to use the food tracker, follow along with healthy eating and living tips from Glooko’s resident dietitian, Bridget Wood, RD, LD, CDCES.

MKT-0417 01